[1] Nguyen JT, Jessri M, Costa-Da-Silva AC, et al. Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies[J]. Int J Mol Sci, 2024, 25(19):10411. [2] Van Lier YF, Vos J, Blom B, et al.Allogeneic hematopoietic cell transplantation, the microbiome, and graft-versus-host disease[J]. Gut Microbes, 2023, 15(1):2178805. [3] Li D, Shan Y, Sun W, et al.Multiple Oral Manifestations in a Patient With Chronic Graft Versus Host Disease: A Case Report[J]. Cureus, 2024, 16(9):e70233. [4] Elad S, Aljitawi O, Zadik Y.Oral Graft-Versus-Host Disease: A Pictorial Review and a Guide for Dental Practitioners[J]. Int Dent J, 2021, 71(1):9-20. [5] Huang J, Jiang Q, Liu J, et al.Two oral verrucous carcinomas in a patient with oral graft vs. host disease- recurrent verrucous carcinoma: a case report[J]. BMC Oral Health, 2025, 25(1):968. [6] Dean D, Sroussi H.Oral Chronic Graft-Versus-Host Disease[J]. Front Oral Health, 2022, 3: 903154. [7] Querzoli G, Gabusi A, Gissi DB, et al.Cell-mediated mucositis of the oral cavity: narrative review on etiology, clinico-pathological aspects and malignant transformation[J]. Pathologica, 2025, 117(2):84-100. [8] Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, et al.Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer[J]. Oral Dis, 2021, 27(8):1862-1880. [9] Carrozzo M, Porter S, Mercadante V, et al.Oral lichen planus: A disease or a spectrum of tissue reactions? Types, causes, diagnostic algorhythms, prognosis, management strategies[J]. Periodontol 2000, 2019, 80(1):105-125. [10] Mokhlesi L, Hayes E.Oral Lichen Planus and Lichenoid Lesions[J]. Prim Dent J, 2025, 14(2):48-57. [11] Pengpis N, Prueksrisakul T, Chanswangphuwana C.Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria[J]. Med Oral Patol Oral Cir Bucal, 2023, 28(2):e167-e173. [12] 中华医学会血液学分会造血干细胞应用学组, 中国抗癌协会血液病转化委员会. 慢性移植物抗宿主病(cGVHD)诊断与治疗中国专家共识(2021年版)[J]. 中华血液学杂志, 2021, 42(4):265-275. [13] 王筱淇, 张曦. 《慢性移植物抗宿主病(cGVHD)诊断与治疗中国专家共识(2024年版)》解读[J]. 临床血液学杂志, 2024, 37(9):597-601. [14] Carr AC, Maggini S.Vitamin C and Immune Function[J]. Nutrients, 2017, 9(11):1211. [15] Pullar JM, Carr AC, Vissers MCM.The Roles of Vitamin C in Skin Health[J]. Nutrients, 2017, 9(8):866. [16] 杜光,赵杰,卜书红,等. 雾化吸入疗法合理用药专家共识(2019年版)[J]. 医药导报, 2019, 38(2):135-146. [17] 中华医学会临床药学分会, 中国医药教育协会药事管理专业委员会, 临床合理用药专业委员会. 雾化吸入疗法合理用药专家共识(2024版)[J]. 医药导报, 2024, 43(9):1355-1368. [18] Zeng Q, Liu Y, Wang S, et al.Significant efficacy of short-course, low-concentration betamethasone mouthwash therapy for severe erosive oral lichen planus: a randomized controlled trial[J]. Clin Oral Investig, 2023, 27(8):4323-4334. [19] Tavares LCP, Caetano LVN, Ianhez M.Side effects of chronic systemic glucocorticoid therapy: what dermatologists should know[J]. An Bras Dermatol, 2024, 99(2):259-268. [20] Poppolo Deus F, Ouanounou A.Chlorhexidine in Dentistry: Pharmacology, Uses, and Adverse Effects[J]. Int Dent J, 2022, 72(3):269-277. [21] Tollemar V, Ström J, Tudzarovski N, et al.Immunohistopathology of oral mucosal chronic graft-versus-host disease severity and duration[J]. Oral Dis, 2023, 29(8):3346-3359. [22] Hong J, Fraebel J, Yang Y, et al.Understanding and treatment of cutaneous graft-versus-host-disease[J]. Bone Marrow Transplant, 2023, 58(12):1298-1313. [23] Hamilton BK.Updates in chronic graft-versus-host disease[J]. Hematology Am Soc Hematol Educ Program, 2021, 2021(1):648-654. [24] Fang Y, Zhu Y, Kramer A, et al.Graft-versus-Host Disease Modulation by Innate T Cells[J]. Int J Mol Sci, 2023, 24(4):4084. [25] Jiang H, Fu D, Bidgoli A, et al.T Cell Subsets in Graft Versus Host Disease and Graft Versus Tumor[J]. Front Immunol, 2021, 12: 761448. [26] Justiz Vaillant AA, Modi P, Mohammadi O.Graft-Versus-Host Disease[M].[Updated 2024 Jun 7]. In: StatPearls[Internet]. Treasure Island (FL):StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538235/ [27] Liu H, Zhou L, Wang X, et al.Dexamethasone upregulates macrophage PIEZO1 via SGK1, suppressing inflammation and increasing ROS and apoptosis[J]. Biochem Pharmacol, 2024, 222: 116050. [28] Ramos GA, Leite TDB, Lobo CB, et al. Treatment of oral chronic graft-versus-host disease: a retrospective cohort study[J]. Einstein (Sao Paulo), 2021, 19: eAO6177. [29] Yang M, Chen J, Wei W.Dimerization of glucocorticoid receptors and its role in inflammation and immune responses[J]. Pharmacol Res, 2021, 166: 105334. [30] Lee H, Myoung H, Kim SM.Review of two immunosuppressants: tacrolimus and cyclosporine[J]. J Korean Assoc Oral Maxillofac Surg, 2023, 49(6):311-323. [31] Auger JP, Zimmermann M, Faas M, et al.Metabolic rewiring promotes anti-inflammatory effects of glucocorticoids[J]. Nature, 2024, 629(8010):184-192. |